Literature DB >> 30482257

Longitudinal Standards for Mid-life Cognitive Performance: Identifying Abnormal Within-Person Changes in the Wisconsin Registry for Alzheimer's Prevention.

Rebecca L Koscik1, Erin M Jonaitis1, Lindsay R Clark1, Kimberly D Mueller1, Samantha L Allison1, Carey E Gleason1, Richard J Chappell2, Bruce P Hermann1, Sterling C Johnson1.   

Abstract

OBJECTIVES: A major challenge in cognitive aging is differentiating preclinical disease-related cognitive decline from changes associated with normal aging. Neuropsychological test authors typically publish single time-point norms, referred to here as unconditional reference values. However, detecting significant change requires longitudinal, or conditional reference values, created by modeling cognition as a function of prior performance. Our objectives were to create, depict, and examine preliminary validity of unconditional and conditional reference values for ages 40-75 years on neuropsychological tests.
METHOD: We used quantile regression to create growth-curve-like models of performance on tests of memory and executive function using participants from the Wisconsin Registry for Alzheimer's Prevention. Unconditional and conditional models accounted for age, sex, education, and verbal ability/literacy; conditional models also included past performance on and number of prior exposures to the test. Models were then used to estimate individuals' unconditional and conditional percentile ranks for each test. We examined how low performance on each test (operationalized as <7th percentile) related to consensus-conference-determined cognitive statuses and subjective impairment.
RESULTS: Participants with low performance were more likely to receive an abnormal cognitive diagnosis at the current visit (but not later visits). Low performance was also linked to subjective and informant reports of worsening memory function.
CONCLUSIONS: The percentile-based methods and single-test results described here show potential for detecting troublesome within-person cognitive change. Development of reference values for additional cognitive measures, investigation of alternative thresholds for abnormality (including multi-test criteria), and validation in samples with more clinical endpoints are needed. (JINS, 2019, 25, 1-14).

Entities:  

Keywords:  Cognitive aging; Conditional standards; Executive function; Memory; Preclinical cognitive decline; Quantile regression

Mesh:

Year:  2018        PMID: 30482257      PMCID: PMC6349483          DOI: 10.1017/S1355617718000929

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  7 in total

1.  Preliminary assessment of connected speech and language as marker for cognitive change in late middle-aged Black/African American adults at risk for Alzheimer's disease.

Authors:  Elizabeth Evans; Sheryl L Coley; Diane C Gooding; Nia Norris; Celena M Ramsey; Gina Green-Harris; Kimberly D Mueller
Journal:  Aphasiology       Date:  2021-06-18       Impact factor: 1.902

2.  Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer's Disease.

Authors:  Kimberly D Mueller; Lianlian Du; Davide Bruno; Tobey Betthauser; Bradley Christian; Sterling Johnson; Bruce Hermann; Rebecca Langhough Koscik
Journal:  Front Psychol       Date:  2022-06-27

3.  Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.

Authors:  Kimberly D Mueller; Rebecca L Koscik; Lianlian Du; Davide Bruno; Erin M Jonaitis; Audra Z Koscik; Bradley T Christian; Tobey J Betthauser; Nathaniel A Chin; Bruce P Hermann; Sterling C Johnson
Journal:  Cortex       Date:  2020-07-31       Impact factor: 4.027

4.  Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease.

Authors:  Eva C Alden; Emily S Lundt; Erin L Twohy; Teresa J Christianson; Walter K Kremers; Mary M Machulda; Clifford R Jack; David S Knopman; Michelle M Mielke; Ronald C Petersen; Nikki H Stricker
Journal:  Alzheimers Dement (Amst)       Date:  2022-07-15

5.  Neuropsychological Decline Stratifies Dementia Risk in Cognitively Unimpaired and Impaired Older Adults.

Authors:  Jean K Ho; Daniel A Nation
Journal:  Front Aging Neurosci       Date:  2022-07-18       Impact factor: 5.702

6.  Amyloid duration is associated with preclinical cognitive decline and tau PET.

Authors:  Rebecca L Koscik; Tobey J Betthauser; Erin M Jonaitis; Samantha L Allison; Lindsay R Clark; Bruce P Hermann; Karly A Cody; Jonathan W Engle; Todd E Barnhart; Charles K Stone; Nathaniel A Chin; Cynthia M Carlsson; Sanjay Asthana; Bradley T Christian; Sterling C Johnson
Journal:  Alzheimers Dement (Amst)       Date:  2020-02-13

7.  Validity Evidence for the Research Category, "Cognitively Unimpaired - Declining," as a Risk Marker for Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Rebecca Langhough Koscik; Bruce P Hermann; Samantha Allison; Lindsay R Clark; Erin M Jonaitis; Kimberly D Mueller; Tobey J Betthauser; Bradley T Christian; Lianlian Du; Ozioma Okonkwo; Alex Birdsill; Nathaniel Chin; Carey Gleason; Sterling C Johnson
Journal:  Front Aging Neurosci       Date:  2021-07-26       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.